The American Veterinary Medical Association (AVMA) today honored Dr. Jim Riviere, distinguished professor emeritus at Kansas State University and North Carolina State University, as the winner of the 2023 AVMA Lifetime Excellence in Research Award
Search our online database of uses, restrictions and required withdrawal times (WDT) for FDA drugs approved in food animal species.
If you are a licensed veterinarians, please use our FREE online submission form for questions regarding accidental chemical contamination or drugs used in an extralabel manner in food animals.
FARAD-recommended Withdrawal Interval Recommendations for selected extra-label uses of a limited number of drugs.
The FDA can limit the prohibition on extra-label use to specific species, indications, dosage forms, routes of administration, or a combination of these, as well as prohibit them from use in any food-producing animal.
Guidance for Industry (GFI) #263
How US FARAD Can Help You Smooth Out the Transition from Over-the-Counter (OTC) Medically Important Antimicrobials (MIAs) for animals to Prescription Status (Rx)
The U.S. Food and Drug Administration is announcing the successful implementation of Guidance for Industry (GFI) #263 to transition Over-the-Counter (OTC) Medically Important Antimicrobials (MIAs) for animals to Prescription Status (Rx)
Listen to the AABP podcast "Guidance for Industry (GFI) #263 is part of the FDA’s five-year plan which will move the remaining medically important antimicrobials under veterinary oversight.
All affected animal drug sponsors opted to either voluntarily change the marketing status of certain MIAs for animals from (OTC) to (Rx) or to voluntarily withdraw approval of their affected OTC animal drug applications.